BioSpace News Archive

Biotech Beach

Emmaus Life Sciences Announces Protocol for Study of Pharmaceutical-grade L-glutamine for the Treatment of Diabetes

Emmaus Life Sciences, Inc., a leader in sickle cell disease treatment, announced the use of its pharmaceutical-grade L-glutamine in a clinical study to determine its efficacy in lowering blood sugar in patients with type II diabetes.

June 24, 2019
·
5 min read
Bruker Announces New Phenomics Research Tools at Metabolomics 2019

At Metabolomics 2019, Bruker highlights innovative mass spectrometry and Nuclear Magnetic Resonance systems and novel high-value solutions for molecular phenomics and clinical metabolomics research.

June 24, 2019
·
5 min read
Policy

Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation

Correvio Pharma Corp. announced it has resubmitted a New Drug Application to the U.S. Food and Drug Administration seeking approval for Brinavess™, its antiarrhythmic drug for the rapid conversion of adult patients with recent onset atrial fibrillation.

June 24, 2019
·
8 min read
ICON and DIA Driving Insights to Action with DIA Live 2019

Social media and news aggregation site will highlight real-time digital conversations at DIA 2019

June 24, 2019
·
6 min read
Business

BioEclipse Therapeutics™ Announces Appointment of New Directors and Series A-1 Financing

$9.3 million raised to date; latest funding to be used to advance lead immunotherapy, CRX-100, into Phase 1b/2a clinical trials in therapy-refractory solid tumors

June 24, 2019
·
6 min read
Deals

AFYX Therapeutics Closes $13 Million Convertible Loan Financing

Funds support the completion of ongoing Phase 2b study in Oral Lichen Planus

June 24, 2019
·
2 min read
FDA

Micro Medical Solutions Receives FDA IDE Approval for Pivotal Clinical Trial of MicroStent

Micro Medical Solutions (MMS), an innovator in the field of microvascular interventions that improve clinical outcomes and quality of life, announced today that it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA)

June 24, 2019
·
4 min read
Pharm Country

Prometheus Research and HealthVerity Announce Selection by Epilepsy Foundation to Develop a Community Data Resource

Epilepsy Foundation, the largest national epilepsy advocacy organization, has selected the team of Prometheus Research and HealthVerity to develop a new data infrastructure capable of creating the largest hub of repurposable data on epilepsy in the world.

June 24, 2019
·
3 min read
Job Trends

Apollo Endosurgery Announces Completion of Patient Enrollment for the Multi-Center ESG Randomized Interventional Trial (MERIT)

Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that the final patient has been enrolled in the Multi-Center ESG Randomized Interventional Trial (MERIT).

June 24, 2019
·
4 min read
Drug Development

NantKwest Launches First-in-class, First-in-human Phase I Clinical Trial With a Targeted PD-L1 t-haNK Cell Therapy in Patients With Solid Tumors

NantKwest Inc. (Nasdaq:NK), today announced that the company’s PD-L1 t-haNK investigational new drug application (IND) has cleared FDA review and the program has now transitioned to a first-in-human clinical trial in patients with locally advanced or metastatic solid cancers

June 24, 2019
·
7 min read